What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Heart failure
- Cardiology
Michael P. Frenneaux focuses on Internal medicine, Cardiology, Heart failure, Endocrinology and Heart disease.
Many of his studies on Internal medicine apply to Anesthesia as well.
His Cardiology research focuses on Diastole and how it relates to Radionuclide ventriculography.
His Heart failure research is multidisciplinary, incorporating elements of Ventricle, Placebo, QRS complex and Ranolazine.
His Placebo study combines topics from a wide range of disciplines, such as Carvedilol, Bisoprolol and Metoprolol Succinate, Metoprolol.
His studies in Endocrinology integrate themes in fields like Hemoglobin and Red blood cell.
His most cited work include:
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) (3995 citations)
- Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. (1045 citations)
- Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. (455 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Cardiology, Heart failure, Ejection fraction and Endocrinology.
His work often combines Internal medicine and In patient studies.
His Cardiology study integrates concerns from other disciplines, such as Anesthesia and Diastole.
His work carried out in the field of Heart failure brings together such families of science as Ventricle, QRS complex and Perhexiline.
His study in Ejection fraction focuses on Stroke volume in particular.
His Hypertrophic cardiomyopathy research is multidisciplinary, relying on both Ventricular tachycardia and Sudden death.
He most often published in these fields:
- Internal medicine (84.10%)
- Cardiology (73.95%)
- Heart failure (40.04%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (84.10%)
- Cardiology (73.95%)
- Heart failure (40.04%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Cardiology, Heart failure, Ejection fraction and Cardiomyopathy.
Michael P. Frenneaux regularly links together related areas like Endocrinology in his Internal medicine studies.
His study focuses on the intersection of Cardiology and fields such as Magnetic resonance imaging with connections in the field of Pulmonary artery and Tako-tsubo Cardiomyopathy.
In his study, Hemodynamics is strongly linked to Blood pressure, which falls under the umbrella field of Heart failure.
Michael P. Frenneaux usually deals with Ejection fraction and limits it to topics linked to Confidence interval and Complex disease, Ventricular vascular coupling and Meta-analysis.
The concepts of his Angina study are interwoven with issues in Placebo, Crossover study, Randomized controlled trial, Surgery and Coronary artery disease.
Between 2013 and 2021, his most popular works were:
- Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction (145 citations)
- Metabolic Impairment in Heart Failure : The Myocardial and Systemic Perspective (139 citations)
- Intravenous sodium nitrite in acute ST-elevation myocardial infarction : a randomized controlled trial (NIAMI) (100 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Heart failure
- Cardiology
Michael P. Frenneaux mainly investigates Internal medicine, Cardiology, Heart failure, Ejection fraction and Cardiomyopathy.
His study looks at the relationship between Internal medicine and fields such as Endocrinology, as well as how they intersect with chemical problems.
The various areas that he examines in his Cardiology study include Prospective cohort study, Magnetic resonance imaging and Diastole.
His Heart failure research incorporates elements of Hemodynamics, Clinical endpoint, Clinical trial and Blood pressure.
Michael P. Frenneaux focuses mostly in the field of Clinical trial, narrowing it down to topics relating to Trimetazidine and, in certain cases, Placebo.
Michael P. Frenneaux has included themes like Steatosis, VO2 max, Lipotoxicity, Myocardial steatosis and Blood sampling in his Ejection fraction study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
